New Hepatitis C Drug Incivek Gets FDA Approval

The FDA has approved Incivek as an add-on to current interferon/ribavirn therapy for hepatitis C infection. Like Victrelis, also approved this month, Incivek greatly boosts the cure rate for hepatitis C.

Click here to read the full story.

Post a Comment

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.